CHOPRA X


Associated tags: Medicine, Health, Pharmaceutical industry, Family, International Council, Family office, Food science, Shopping, Executive director, CPG, Metabolism, Associate, Edelbrock, Mastercard, Spagnuolo, Fraud, SP, University, Research, Corporation

SP NUTRACEUTICALS ENTERS NEXT CHAPTER OF BUSINESS GROWTH WITH NEW INVESTMENT PARTNER, CHOPRAX VENTURES, AND APPOINTMENT OF NEW CEO AND BOARD OF DIRECTORS

Retrieved on: 
Tuesday, December 5, 2023

BURLINGTON, ON, Dec. 5, 2023 /PRNewswire/ -- Today, SP Nutraceuticals announced a strategic partnership and equity agreement with ChopraX Ventures, led by its renowned clinician and Chairman Dr. Deepak Chopra, a pioneer at the forefront of medicine for the past 50 years. Simultaneously, SP Nutraceuticals announced a new slate of senior leadership and advisory members, including the appointment of Darren Contardo, current President of the company, as the new Chief Executive Officer, effective as of November 6, 2024. Darren will retain the President title. SP Nutraceuticals' flagship brand Metavo offers a suite of metabolism products which aim to support metabolic health.

Key Points: 
  • SP Nutraceuticals' flagship brand Metavo offers a suite of metabolism products which aim to support metabolic health.
  • "We are excited to collaborate with SP Nutraceuticals and actively pursue breakthrough innovations in metabolic health," said David Lubotta, Managing Partner of ChopraX Ventures.
  • "I am honored to step into the position of CEO of SP Nutraceuticals in this exciting phase of growth," said Darren Contardo, CEO of SP Nutraceuticals.
  • New board members include:
    Trevor Clarke, former CEO of SP Nutraceuticals, will now serve as the Executive Director and Corporate Secretary.